Completed from United Kingdom
I signed up for the Pharmacoeconomics course hoping to get a grip on budgeting for new medicines, and it definitely delivered. The bite‑size video lessons made the complex maths feel manageable, and the interactive quizzes helped cement concepts like QALY calculations. I especially liked the practical assignment where we had to assess the cost‑effectiveness of a vaccine program – I used that work in a volunteer project with a local NHS trust. The course material was spot‑on, though I wish there were a few more live Q&A sessions. Still, a solid learning experience that met my expectations.
The Pharmacoeconomics course at Stanmore School of Business precisely matched my learning objectives. The modules on cost‑utility analysis gave me the confidence to build a full economic model for a new oncology drug, which I later presented to my employer’s senior management. The case studies from real‑world pharmaceutical firms were exceptionally relevant, and the downloadable Excel templates saved me countless hours. Overall, the instruction was clear, the materials were up‑to‑date, and I feel fully equipped to apply pharmacoeconomic principles in my role as a health‑policy analyst.
Wow! This Pharmacoeconomics class was a game‑changer for my career in pharma consulting. The instructor’s enthusiastic style made even the toughest topics, like incremental cost‑effectiveness ratios, exciting. I walked away with hands‑on skills in building budget impact models using the provided R scripts—something I immediately applied to a client project on biosimilar adoption in India. The course pack included up‑to‑date WHO guidelines and real‑case PDFs that were incredibly useful. I’m thrilled with the knowledge I gained and can already see the impact on my consulting work.
The Pharmacoeconomics program offered by Stanmore School of Business is impressively thorough. Over the six weeks, I delved into topics ranging from sensitivity analysis to health‑technology assessment frameworks, each supported by detailed lecture notes and real‑world datasets from African health ministries. A standout moment was the capstone project where I performed a cost‑benefit analysis for a malaria vaccine rollout; the step‑by‑step guidance and the instructor’s feedback were invaluable. While the pacing was brisk, the quality of the resources and the relevance to my work as a policy analyst made the experience highly rewarding.
